Efficacy of nightly 0.01% atropine in controlling myopia progression in Lebanese children: A 24-month retrospective cohort study

doi:10.5318/wjo.121730

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 10, Issue 1

This Article

(1)

(0)

(3)

Peer-Review Report of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Journal Information of This Article

Publication Name

World Journal of Ophthalmology

ISSN

2218-6239

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Cohort Study

Copyright: ©Author(s) 2026. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution-NonCommercial (CC BY-NC 4.0) license. No commercial re-use. See permissions. Published by Baishideng Publishing Group Inc.

World J Ophthalmol. Sep 12, 2026; 10(1): 121730
Published online Sep 12, 2026. doi: 10.5318/wjo.121730

Table 1 Inter-period change in spherical equivalent refraction between the atropine and control groups (mean ± SD, diopters)

Time interval	Control group (n = 35)	Atropine group (n = 35)	P value
0-6 months vs baseline	0.51 ± 0.46	0.26 ± 0.29	0.008^b
6-12 months	0.31 ± 0.29	0.31 ± 0.34	1.00
12-18 months	0.37 ± 0.32	0.18 ± 0.25	0.009^b
18-24 months	0.42 ± 0.31	0.29 ± 0.24	0.071

^bP < 0.01 vs control group.

Full Size Table

Table 2 Absolute spherical equivalent refraction values at each time point for the atropine and control groups (mean ± SD, diopters)

Time interval	Control group (n = 35)	Atropine group (n = 35)	P value
Baseline	2.71 ± 0.98	3.99 ± 1.50	< 0.001^b
6 months	3.22 ± 1.07	4.24 ± 1.49	0.003^b
12 months	3.54 ± 1.09	4.52 ± 1.44	0.003^b
18 months	3.91 ± 1.13	4.73 ± 1.50	0.015^a
24 months	4.33 ± 1.25	5.01 ± 1.49	0.057

^aP < 0.05 vs control group.

^bP < 0.01 vs control group.

Full Size Table

Citation: Abi Rached AJ, El Halabi CK, Tlaiss Y, Dounia MJ, Saadeh A. Efficacy of nightly 0.01% atropine in controlling myopia progression in Lebanese children: A 24-month retrospective cohort study. World J Ophthalmol 2026; 10(1): 121730
URL: https://www.wjgnet.com/2218-6239/full/v10/i1/121730.htm
DOI: https://dx.doi.org/10.5318/wjo.121730

Abi Rached AJ, El Halabi CK, Tlaiss Y, Dounia MJ, Saadeh A. Efficacy of nightly 0.01% atropine in controlling myopia progression in Lebanese children: A 24-month retrospective cohort study. World J Ophthalmol 2026; 10(1): 121730 [DOI: 10.5318/wjo.121730]

All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.